Geno Pharmaceuticals
 
 
 
Fusigen Spray
Fusigen - Clinical trial Report

 Fusigen - Clinical trial Report:

Ref: Clinical Report Study No: FUS/011/08. Ver 0.0
QUEST LIFE SCIENCES PVT LTD, SDF III,MEPZ, TAMBARAM, CHENNAI – 600045, INDIA
 
Objective:
To study the effect of Fusigen spray in surgical, contaminated and ortho¬paedic injuries and compare the effect of Fusigen spray with that of Povidone Iodine and Metronidazole.
 
Design:
Open label randomized controlled trial of Fusigen spray with Povidone Iodine and Metronidazole.
No. of patients
20 male' patients were enrolled into the study
 
Patient's profile:
§08 compound injuries
•04 LSCS
•04 Post operative surgeries
02 post operative ortho
•02 laparotomy
Clinical trial:
50% of the group received Fusigen spray and the remaining 50% received Povidone Iodine and Metronidazole. Both the drugs were applied and closely followed up till wound healing.
Result
Wound is clean, healthy and healing faster with no bacterial infection
 
Observation:
•It was observed that Fusigen spray showed wound healing faster with no bacterial infection as compared to Povidone Iodine and Metronidazole
•No local (allergic dermatitis) or Systemic (anaphylactic Shock) reactions
•No irritation or burning sensation during spraying
•No change in metabolism, blood cell count and no biochemical changes
 
Tolerance:
Fusigen spray is well tolerated and accepted by patients with no adverse effects
 
Conclusion:
Fusigen spray is better than Povidone Iodine and Metronidazole for treating surgical wounds
 

Patent Certificate
Read More
©2018 Reserved by Geno Pharmaceuticals Pvt. Ltd.
Developed by APJ Systems
Best view at 1024 x 768 resolution